A Lyme disease vaccine could be on its way soon, according to pharmaceutical company Moderna.
The company has announced two new mRNA vaccines in development that could prevent Lyme disease, marking the "first application of its mRNA technology to bacterial pathogens." The technology was used in creating the COVID-19 vaccine. Moderna also announced vaccine development plans for norovirus and RSV, which have both been spreading rapidly.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There has only been one human Lyme disease vaccine that was ever available on the market and it was pulled in 2002 because "negative press coverage and limited awareness of the benefits of the vaccine decreased consumer demand for the vaccine," according to a 2007 study. However, there are approximately 120,000 reported cases of Lyme reported each year in the U.S. and Europe, and that number is rising due to climate change, per Axios.
Pfizer and its partner company Valneva also have a Lyme disease vaccine in the works that has shown promise, with the company saying it could get approved as early as 2025. It is still good practice to wear long sleeves and use insect repellant to prevent tick bites in the first place, but "after years of relying on such preventive steps, an age of advanced drugs and vaccines could be nigh," Axios writes.
-
Nepal chooses toddler as its new ‘living goddess’Under the Radar Girls between two and four are typically chosen to live inside the temple as the Kumari – until puberty strikes
-
October 5 editorial cartoonsCartoons Sunday's political cartoons include half-truth hucksters, Capitol lockdown, and more
-
Jaguar Land Rover’s cyber bailoutTalking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
‘Nightmare bacteria’ are rapidly spreadingUnder the radar The infections are largely resistant to antibiotics
-
Kissing bug disease has a growing presence in the USThe explainer The disease has yielded a steady stream of cases in the last 10 years
-
Climate change is making us eat more sugarUnder the radar Sweets make the heat feel more manageable
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
Trump makes unmoored claims on Tylenol and autismSpeed Read No causal relationship has been established between autism and acetaminophen use during pregnancy
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
